Login / Signup

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.

François BertucciAnthony GonçalvesArnaud GuilleJosé AdelaïdeSéverine GarnierNadine CarbucciaEmilien BillonPascal FinettiPatrick SfumatoAudrey MonneurChristophe PécheuxMartin KhranSerge BrunelleLenaïg MescamJeanne Thomassin-PianaFlora PoizatEmmanuelle Charafe-JauffretOlivier TurriniEric LambaudieMagali ProvansalJean-Marc ExtraAnne MadroszykMarine GilabertRenaud SabatierCécile VicierEmilie MamessierChristian ChabannonJihane PakradouniPatrice ViensFabrice AndréGwenaelle GravisCornel PopoviciDaniel BirnbaumMax Chaffanet
Published in: Genome medicine (2021)
ID-RCB identifier: 2014-A00966-41; ClinicalTrials.gov identifier: NCT02342158 .
Keyphrases
  • high throughput
  • clinical trial
  • single cell
  • phase ii
  • open label
  • genome wide
  • double blind
  • study protocol
  • phase iii
  • randomized controlled trial
  • dna methylation